Herceptin
October 1998
Herceptin will be a big breakthrough. It's coming out now in the U.S...soon in Canada.
Herceptin is the first monoclonal antibody for breast cancer.
It targets HER2...a protein that stimulates the growth of breast cancer cells. About 30% of women with breast cancer have tumours that produce excessive amounts of HER2.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote